Cargando…

How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in Germany

INTRODUCTION: Germany is experiencing the second COVID-19 pandemic wave. The intensive care unit (ICU) bed capacity is an important consideration in the response to the pandemic. The purpose of this study was to determine the costs and benefits of maintaining or expanding a staffed ICU bed reserve c...

Descripción completa

Detalles Bibliográficos
Autor principal:	Gandjour, Afschin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801567/ https://www.ncbi.nlm.nih.gov/pubmed/33433853 http://dx.doi.org/10.1007/s40258-020-00632-2

Ejemplares similares

A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany
por: Gandjour, Afschin
Publicado: (2023)

Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results
por: Gandjour, Afschin
Publicado: (2020)

The clinical and economic value of a successful shutdown during the SARS-CoV-2 pandemic in Germany
por: Gandjour, Afschin
Publicado: (2022)

Long COVID: Costs for the German economy and health care and pension system
por: Gandjour, Afschin
Publicado: (2023)

Costs of patients with chronic kidney disease in Germany
por: Gandjour, Afschin, et al.
Publicado: (2020)

A parsimonious model to validate cost-effectiveness analyses on preventive health care
por: Gandjour, Afschin
Publicado: (2021)

Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment
por: Gandjour, Afschin
Publicado: (2023)

Benefits, risks, and cost-effectiveness of COVID-19 self-tests from a consumer’s perspective
por: Gandjour, Afschin
Publicado: (2022)

Was EU’s COVID-19 vaccine procurement strategy irrational? A re-analysis based on cost-effectiveness considerations
por: Gandjour, Afschin
Publicado: (2022)

Financial Incentives in the Path to Recovery from the COVID-19 Pandemic
por: Gandjour, Afschin
Publicado: (2021)

Optimal allocation of scarce PCR tests during the COVID-19 pandemic
por: Gandjour, Afschin
Publicado: (2023)

Comment on “Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective”
por: Gandjour, Afschin
Publicado: (2022)

Predictors of negotiated prices for new drugs in Germany
por: Gandjour, Afschin, et al.
Publicado: (2020)

Value-based pricing of a COVID-19 vaccine
por: Gandjour, Afschin
Publicado: (2022)

COVID-19 and the forgone health benefits of elective operations
por: Gandjour, Afschin
Publicado: (2022)

Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiG
por: Gandjour, Afschin
Publicado: (2020)

A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency
por: Gandjour, Afschin
Publicado: (2020)

Deterministic Sensitivity Analysis Under Ignorance
por: Gandjour, Afschin
Publicado: (2021)

The price of curing cancer
por: Gandjour, Afschin
Publicado: (2021)

Demonstrating the value of cancer biomarkers at the population level
por: Gandjour, Afschin
Publicado: (2022)

How Many Hospital Beds Are Required to Train a Nurse?
Publicado: (1920)

Pharmaceutical expenditure and gross domestic product: Evidence of simultaneous effects using a two‐step instrumental variables strategy
por: Shaikh, Mujaheed, et al.
Publicado: (2018)

Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in The Netherlands – A Markov Model
por: Adarkwah, Charles Christian, et al.
Publicado: (2011)

ICU bed reserve capacity for COVID-19 cost effective in Germany
Publicado: (2021)

How to justify a ban on doping?
por: Breitsameter, Christof
Publicado: (2017)

Intensive Care Unit Services Preparedness for the Pandemic: An Efficiency Analysis
por: Cinaroglu, Songul
Publicado: (2021)

Evaluating compulsory minimum volume standards in Germany: how many hospitals were compliant in 2004?
por: de Cruppé, Werner, et al.
Publicado: (2007)

How many holes is too many? A prototype tool for estimating mosquito entry risk into damaged bed nets
por: Sutcliffe, James, et al.
Publicado: (2017)

Cost-justifying usability: an update for the internet age
por: Bias, Randolph G, et al.
Publicado: (2005)

Offline: How to fix pandemic preparedness
por: Horton, Richard
Publicado: (2022)

Intensive Care Unit Preparedness During Pandemics and Other Biological Threats
por: Maves, Ryan C., et al.
Publicado: (2019)

How Many People Need Palliative Care and How Many Miss Out?
por: Davis, Esther, et al.
Publicado: (2020)

ECMO during the COVID-19 pandemic: When is it justified?
por: Heinsar, Silver, et al.
Publicado: (2020)

Critical care capacity during the COVID-19 pandemic: Global availability of intensive care beds
por: Ma, Xiya, et al.
Publicado: (2020)

How Far Are We Justified in Anticipating Proximate Decay?
por: Swain, E. D.
Publicado: (1875)

Effects on LOS may not justify cost of remdesivir for severe COVID-19
Publicado: (2021)

Value of information analysis for pandemic response: intensive care unit preparedness at the onset of COVID-19
por: Eze, Peter U., et al.
Publicado: (2023)

The association between system-justifying ideologies and attitudes toward the social market economy in Germany
por: Jedinger, Alexander, et al.
Publicado: (2023)

Management of bed availability in intensive care in the context of hospitalization by court order
por: Vargas, Mara Ambrosina de Oliveira, et al.
Publicado: (2020)

COVID-19 pandemic: Hospital preparedness in a tertiary care hospital in North East India
por: Pandita, Kawal Krishan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g0u52dhavadf45h5h8j9a2h7ta